MIDTERMS: Parkinson's Disease Flashcards

1
Q

What are the cardinal features of Parkinson’s Disease (PD)?

A

Rigidity, bradykinesia, tremors, and postural instability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who first described Parkinson’s Disease and in what year?

A

James Parkinson in 1817, referring to it as “the shaking palsy.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the most common form of Parkinson’s Disease?

A

Idiopathic Parkinson’s Disease, affecting approximately 78% of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does the incidence of Parkinson’s Disease change with age?

A

Incidence increases dramatically with age, affecting more than 2% of the population older than 65.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the average age of onset for Parkinson’s Disease?

A

50 to 60 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Are men or women more frequently affected by Parkinson’s Disease?

A

Men are affected 1.2 to 1.5 times more frequently than women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some identifiable causes of secondary parkinsonism?

A

Viruses, toxins, drugs, and tumors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name a group of drugs that can induce parkinsonian symptoms.Name a group of drugs that can induce parkinsonian symptoms.

A

Neuroleptic drugs, antidepressants, and antihypertensives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name two conditions included in parkinsonism-plus syndromes.

A

Progressive supranuclear palsy and corticobasal ganglionic degeneration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What defines parkinsonism-plus syndromes?

A

A group of neurodegenerative diseases that produce parkinsonian symptoms along with additional neurological signs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is toxic parkinsonism, and who is at risk?

A

Toxic parkinsonism occurs in individuals exposed to environmental toxins, particularly manganese, which is a hazard for miners.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is X-linked dystonia parkinsonism, also known as “Lubag Syndrome”?

A

A movement disorder first reported in 1975, affecting Filipino adult males, particularly those from the island of Panay.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What differentiates Progressive Supranuclear Palsy (PSP) from Parkinson’s Disease?

A

PSP features early onset of balance and eye movement abnormalities, faster progression, and minimal tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the key characteristics of Multiple System Atrophy (MSA)?

A

MSA is characterized by early autonomic dysfunction, cerebellar signs, and a lack of tremor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In Corticobasal Degeneration (CBD), what symptoms may be present?

A

CBD presents with asymmetric rigidity, apraxia, dystonia, and cognitive decline.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the prominent features of Lewy Body Dementia (LBD)?

A

LBD is characterized by cognitive decline with parkinsonism, visual hallucinations, and fluctuations in consciousness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does Essential Tremor (ET) differ from Parkinson’s Disease?

A

ET involves postural and action tremors without bradykinesia or rigidity.

9
Q

What is the primary pathophysiological change in Parkinson’s Disease?

A

Progressive degeneration of dopamine levels in the basal ganglia, particularly in the pars compacta of the substantia nigra.

10
Q

How does dopamine influence movement in the context of Parkinson’s Disease?

A

Dopamine influences the encoding of movement that activates upper motor neurons to coordinate and smooth movements.

11
Q

What are the hallmark symptoms of Parkinson’s Disease?

A

Rigidity, bradykinesia, tremors, and postural instability (typically in later stages).

12
Q

Describe the primary motor symptoms associated with Parkinson’s Disease.

A

Primary motor symptoms include rigidity (cogwheel and lead pipe), bradykinesia, tremor (resting tremor), and postural instability.

12
Q

What does Stage I of the Hoehn & Yahr classification indicate?

A

Stage I indicates minimal or absent symptoms, with unilateral involvement if present.

12
Q

What are some secondary motor symptoms seen in Parkinson’s Disease?

A

Secondary motor symptoms include muscle performance issues, fatigue, and gait disturbances (freezing and festinating gait).

13
Q

What is bradykinesia, and how does it manifest in Parkinson’s Disease?

A

Bradykinesia is slowness of movement characterized by reduced speed, range, and amplitude of movements, often leading to hypomimia (masked facial expression).

13
Q

List some non-motor symptoms of Parkinson’s Disease.

A

Non-motor symptoms can include sensory issues, dysphagia, speech difficulties, cognitive decline, depression, anxiety, autonomic dysfunction, and sleep disorders.

13
Q

Define rigidity in the context of Parkinson’s Disease.

A

Rigidity is increased resistance to passive motion regardless of movement velocity, often described as “heaviness” and “stiffness.”

13
Q

What are the two types of rigidity observed in Parkinson’s Disease?

A

Cogwheel rigidity (jerky resistance to movement) and lead pipe rigidity (sustained, prolonged rigidity).

13
Q

How is a tremor described in patients with Parkinson’s Disease?

A

Tremor is typically a resting tremor, initially occurring in one hand or foot and often described as a “pill-rolling” motion.

14
Q

What contributes to postural instability in Parkinson’s Disease?

A

Postural instability results from abnormal postural responses, narrowing base of support, and factors such as rigidity, decreased muscle torque production, loss of range of motion, and weakness.

15
Q

What is the average duration of Parkinson’s Disease and its impact on life expectancy?

A

The mean duration of PD is approximately 10 to 20 years, with life expectancy nearly equal to that of the general population.

15
Q

How long is the preclinical period for Parkinson’s Disease, and what does it imply?

A

The preclinical period can last from 5 to 25 years, during which there are no apparent clinical manifestations of the disease.

16
Q

What characterizes the PIGD group in Parkinson’s Disease?

A

Patients in the PIGD group present with postural instability and gait disturbances, leading to more pronounced deterioration and rapid disease progression.

17
Q

What is characteristic of Stage III in the Hoehn & Yahr classification?

A

Stage III is marked by impaired righting reflexes, unsteadiness when turning or rising from a chair, and some activity restrictions, though the patient can live independently.

17
Q

What does Stage V of the Hoehn & Yahr classification indicate regarding mobility?

A

Stage V indicates that the patient is confined to bed or a wheelchair, with severe symptoms present.

18
Q

What is the purpose of the Unified Parkinson’s Disease Rating Scale (UPDRS)?

A

The UPDRS is the gold standard for measuring the progression of Parkinson’s Disease, assessing non-motor and motor aspects of daily living.

19
Q

What are the four parts of the UPDRS?

A

Non-Motor aspects of experiences of daily living.
Motor experiences of daily living.
Motor examination.
Motor complications.

20
Q

What is the recommended approach for strength training in older adults with Parkinson’s Disease?

A

Begin at a lower intensity, perform exercises 2 days per week on nonconsecutive days, and consider using machines for safety.

21
Q

What should be included in balance training for PD patients?

A

Training should consider the patient’s limitations and include dynamic stability tasks and control of center of mass (COM) and limits of stability (LOS).

22
Q

How does aerobic exercise benefit individuals with Parkinson’s Disease?

A

Improves oxygen consumption (VO2), reduces motor disease severity, and enhances functional outcomes.

23
Q

Check CE1 flashcards

A

<3